QuidelOrtho Corp. (QDEL)
16.58
+0.15
(+0.91%)
USD |
NASDAQ |
Apr 01, 16:00
16.41
-0.17
(-1.03%)
Pre-Market: 08:35
QuidelOrtho Research and Development Expense (TTM) : 186.20M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Boston Scientific Corp. | 2.052B |
| Integer Holdings Corp. | 49.50M |
| Insulet Corp. | 301.10M |
| Tandem Diabetes Care, Inc. | 192.28M |
| Establishment Labs Holdings, Inc. | 20.25M |